Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors.

Literature DB >> 25054459

Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors.

David S Wolf¹, Kenneth J Cohen.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2013 PMID： 25054459 PMCID： PMC6166528 DOI： 10.2217/cns.13.14

Source DB: PubMed Journal: CNS Oncol ISSN： 2045-0907

Keyword Cloud
References

× No keyword cloud information.

14 in total

1. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.

Authors: M C Chamberlain
Journal: Pediatr Neurol Date: 2001-02 Impact factor: 3.372

2. Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

Authors: Andreas Peyrl; Monika Chocholous; Mark W Kieran; Amedeo A Azizi; Christina Prucker; Thomas Czech; Karin Dieckmann; Maria-Theresa Schmook; Christine Haberler; Ulrike Leiss; Irene Slavc
Journal: Pediatr Blood Cancer Date: 2011-12-06 Impact factor: 3.167

Review 3. Metronomic chemotherapy: new rationale for new directions.

Authors: Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal: Nat Rev Clin Oncol Date: 2010-06-08 Impact factor: 66.675

4. Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience.

Authors: D Zapletalova; N André; L Deak; M Kyr; V Bajciova; P Mudry; L Dubska; R Demlova; Z Pavelka; K Zitterbart; J Skotakova; K Husek; A Martincekova; P Mazanek; T Kepak; M Doubek; L Kutnikova; D Valik; J Sterba
Journal: Oncology Date: 2012-04-24 Impact factor: 2.935

5. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity.

Authors: G Klement; S Baruchel; J Rak; S Man; K Clark; D J Hicklin; P Bohlen; R S Kerbel
Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808

6. Treatment with oral etoposide for childhood recurrent ependymomas.

Authors: Alessandro Sandri; Maura Massimino; Luana Mastrodicasa; Nicola Sardi; Daniele Bertin; Maria Eleonora Basso; Liana Todisco; Alessandra Paglino; Giorgio Perilongo; Lorenzo Genitori; Laura Valentini; Umberto Ricardi; Lorenza Gandola; Felice Giangaspero; Enrico Madon
Journal: J Pediatr Hematol Oncol Date: 2005-09 Impact factor: 1.289

7. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.

Authors: Mark W Kieran; Christopher D Turner; Joshua B Rubin; Susan N Chi; Mary Ann Zimmerman; Christine Chordas; Giannoula Klement; Andrea Laforme; Amanda Gordon; Amanda Thomas; Donna Neuberg; Timothy Browder; Judah Folkman
Journal: J Pediatr Hematol Oncol Date: 2005-11 Impact factor: 1.289